PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
06-Aug-2024 Cosmos Health Reports Full Year 2023 Results: Revenue Increases to $53.4M, or 6% YoY; Stockholders' Equity Remains Near Record Highs at $36M, or $2.25 per Share AccessWire
06-Aug-2024 OS Therapies Announces Osteosarcoma Scientific and Medical Advisory Board AccessWire
06-Aug-2024 Catheter Precision, Inc. Announces Publication of LockeT Data in the Journal of Cardiovascular Electrophysiology AccessWire
06-Aug-2024 Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations AccessWire
06-Aug-2024 Sunshine Biopharma Announces Reverse Stock Split AccessWire
06-Aug-2024 Ainos Concludes Growth Financing From Lind Partners AccessWire
06-Aug-2024 Acreage Commences Non-Medical Cannabis Sales in Ohio AccessWire
06-Aug-2024 Protagonist Reports Second Quarter 2024 Financial Results and Provides Corporate Update AccessWire
05-Aug-2024 Ainos Reports Second Quarter 2024 Financial Results AccessWire
05-Aug-2024 Houston Medical Waste Disposal Company Tackles Piercing Surge in Needlestick Injuries With Essential Guide AccessWire
05-Aug-2024 Jaguar Health Issues Shareholder Letter: Company to Explore Approval Pathway for Crofelemer in Breast and Lung Cancer Based on Phase 3 Results - Investor Webcast August 13th Will Review Q2 Earnings and Further Review OnTarget Trial’s Clinically Meaningful Results AccessWire
05-Aug-2024 Vascular Therapies Completes Enrollment in the ACCESS 2 Study, a Phase III Multinational Randomized Clinical Trial of the Sirolimus Eluting Collagen Implant (Sirogen) for the Surgical Creation of Arteriovenous Fistula for Hemodialysis Vascular Access AccessWire
05-Aug-2024 Transforming Aesthetics: Dr. Maria Fedchuk's Journey of Innovation at MTS US AccessWire
05-Aug-2024 IntoValue, Inc, Welcomes Steve Nelson to Board of Directors AccessWire
05-Aug-2024 BIO-Europe(R) Celebrates 30th Anniversary with Landmark Event in Stockholm AccessWire
05-Aug-2024 Avinger Appoints Thomas P. Davis, MD, FACC as Chief Medical Officer AccessWire
05-Aug-2024 Relief Therapeutics Secures up to $11 Million from Royalty Sales AccessWire
02-Aug-2024 American Society for Transplantation and Cellular Therapy Applauds FDA Approval of TECELRA(R) for Synovial Sarcoma Treatment AccessWire
02-Aug-2024 KARE PharmTech Hosts Empowered Pharmacies Futures Summit to Transform Community Pharmacies AccessWire
02-Aug-2024 Neighborhood LTC Pharmacy Announces New Technology Partnership With Impruvon Health AccessWire